WACKER Invests in Amsterdam Biotech Site
The investment price is a mid-double-digit million-euro amount
30-Jul-2020 -
WACKER, the Munich-based chemicals Group, is investing in its production facilities for biologics, LMPs (live microbial products) and vaccines at its Amsterdam site. Projects include the construction of a new fermentation line with a volume of 1,500 liters as well as the setting up of new ...
investments
mRNA vaccines